Khechen Benjamin, Haws Brittany E, Bawa Mundeep S, Patel Dil V, Bawa Harmeet S, Massel Dustin H, Mayo Benjamin C, Cardinal Kaitlyn L, Guntin Jordan A, Singh Kern
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois.
Int J Spine Surg. 2019 Apr 30;13(2):162-168. doi: 10.14444/6022. eCollection 2019 Apr.
Several studies have compared outcomes between hospital-based centers (HBCs) and ambulatory surgery centers (ASCs) following minimally invasive lumbar decompression (MIS LD). However, the association between narcotic consumption and pain in the immediate postoperative period has not been well characterized. As such, this study aims to examine pain, narcotic consumption, and length of stay (LOS) among patients discharged on postoperative day 0 following a 1-level MIS LD between HBCs or ASCs.
Patients who underwent a primary, 1-level MIS LD were retrospectively reviewed and stratified by operative location. Differences between groups in patient demographics were assessed using independent-sample tests for continuous variables and χ analysis for categoric variables. The operative location and its effect on perioperative characteristics, inpatient pain scores, and narcotics consumption were analyzed using multivariate linear regression adjusted for significant patient characteristics.
There were 235 patients identified, of whom 90 and 145 underwent surgery at an HBC or ASC, respectively. The HBC cohort exhibited an increased comorbidity burden and had a greater percentage of privately insured patients. The HBC cohort recorded shorter operative time and greater total estimated blood loss. Patients in the HBC cohort experienced prolonged LOS, and consumed greater total oral morphine equivalents compared with the ASC cohort. No differences were observed in the remaining outcomes.
The results of the current study suggest that patients who underwent MIS LD at an ASC received fewer narcotics than patients treated at an HBC, which may contribute to shortened LOS. Additionally, there was no difference in patient-reported pain between cohorts despite the differences in narcotic use. As such, postoperative narcotics administration varied, indicating HBC patients perhaps required more narcotic pain medications to achieve the same pain scores that were sufficient enough to allow patient discharge, thus prolonging LOS.
III.
多项研究比较了基于医院的中心(HBCs)和门诊手术中心(ASCs)在微创腰椎减压术(MIS LD)后的结局。然而,术后即刻麻醉药物消耗与疼痛之间的关联尚未得到充分描述。因此,本研究旨在探讨在HBCs或ASCs接受单节段MIS LD术后第0天出院的患者的疼痛、麻醉药物消耗及住院时间(LOS)。
对接受初次单节段MIS LD的患者进行回顾性分析,并根据手术地点进行分层。使用独立样本t检验评估连续变量组间患者人口统计学差异,使用χ²分析评估分类变量差异。采用多因素线性回归分析手术地点及其对围手术期特征、住院患者疼痛评分和麻醉药物消耗的影响,并对显著的患者特征进行校正。
共纳入235例患者,其中90例和145例分别在HBC或ASC接受手术。HBC队列的合并症负担较重,私人保险患者比例较高。HBC队列的手术时间较短,但估计总失血量较多。与ASC队列相比,HBC队列的患者住院时间延长,口服吗啡当量总量更高。其余结局未见差异。
本研究结果表明,在ASC接受MIS LD的患者比在HBC接受治疗的患者使用的麻醉药物更少,这可能有助于缩短住院时间。此外,尽管麻醉药物使用存在差异,但队列间患者报告的疼痛无差异。因此,术后麻醉药物的使用存在差异,表明HBC患者可能需要更多的麻醉性镇痛药才能达到足以允许患者出院的相同疼痛评分,从而延长了住院时间。
III级